CJC-1295 5mg, Ipamorelin 5mg (10mg Blend)

$54.99

  • CJC-1295 (No DAC): 5mg
  • Ipamorelin: 5mg
  • Total Material: 10mg
  • Vial Size: 3mL
  • CJC Molecular Formula: C152H252N44O42
  • CJC Molecular Weight: 3367.9 g/mol
  • CJC PubChem CID: 56841945
  • Ipamorelin Molecular Formula: C38H49N9O5
  • Ipamorelin Molecular Weight: 711.9 g/mol
  • Ipamorelin PubChem CID: 9831659
  • Intended Use: Controlled laboratory research only

50 in stock

SKU: LPCJCIPA10 Categories: , Tags: ,
Description

CJC-1295 No DAC 5mg / Ipamorelin 5mg – Advanced 10mg Research Blend

CJC-1295 No DAC 5mg / Ipamorelin 5mg is a two-component research formulation containing 10mg total specified material in a 3mL vial. Equal listed quantities of the two components provide a clearly documented blend for controlled laboratory investigation.

Each material has separately supplied sequence, molecular formula, molecular weight, and PubChem information for research identification and recordkeeping.

CJC-1295 No DAC / Ipamorelin Research Overview

The formulation contains two independently specified research materials:

Specification No DAC Component Ipamorelin
Quantity 5mg 5mg
Molecular Formula C152H252N44O42 C38H49N9O5
Molecular Weight 3367.9 g/mol 711.9 g/mol
PubChem CID 56841945 9831659

Total Material: 10mg
Vial Size: 3mL

The individual quantities and vial capacity describe the supplied product. They do not establish an experimental concentration, human dose, or administration protocol.

Molecular Specifications of the No DAC Component

The supplied sequence is:

H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

Its molecular formula is:

C152H252N44O42

The stated molecular weight is 3367.9 g/mol, with a supplied PubChem CID of 56841945.

These molecular characteristics provide reference points for research documentation and material identification.

No CAS number was included in the supplied specifications, so one is not being inferred.

Ipamorelin 5mg Molecular Specifications

The second component contains 5mg of Ipamorelin.

Its supplied sequence is:

H-Aib-His-D-2Nal-D-Phe-Lys-NH2

The molecular formula is C38H49N9O5, while the supplied molecular weight is 711.9 g/mol and the PubChem CID is 9831659.

Researchers can examine the supplied formula through the PubChem molecular formula search for C38H49N9O5.

No CAS number was supplied for this component, so none is being added.

Two-Component 10mg Research Blend

This formulation contains:

No DAC component: 5mg
Ipamorelin: 5mg

Together, these quantities provide:

10mg total specified research material

Research involving either isolated component should be distinguished from investigation of the combined formulation.

Results obtained from one component independently should not automatically be generalized to a multi-component experimental system.

Molecular Identification and Verification

Material identification should rely on the complete supplied molecular specifications rather than naming conventions alone.

For the first component, researchers have its sequence, C152H252N44O42 molecular formula, 3367.9 g/mol molecular weight, and PubChem CID 56841945.

The second component is documented through its separate sequence, C38H49N9O5 molecular formula, 711.9 g/mol molecular weight, and PubChem CID 9831659.

These specifications can be recorded alongside experiment-specific conditions when evaluating scientific literature or laboratory results.

3mL Research Vial

The complete 10mg formulation is supplied in a 3mL vial.

Vial capacity is a physical product specification. It does not independently determine a final preparation volume, experimental concentration, or administration volume.

No solvent, reconstitution procedure, storage requirement, or experimental concentration was supplied with the provided product information.

Those details are therefore not being inferred.

Research Considerations

Controlled investigation of a two-component research blend requires clear documentation of both materials.

Relevant variables can include:

  • Identity of each component
  • Individual material quantity
  • Molecular characteristics
  • Experimental concentration
  • Research model
  • Appropriate controls
  • Exposure conditions
  • Analytical methodology
  • Experimental endpoints
  • Reproducibility
  • Data interpretation

Experimental findings should remain associated with the conditions and research model in which they were produced.

Experimental Documentation

Laboratory records can separately document each material included in the blend.

For the first component, records may include its sequence, formula, molecular weight, PubChem identifier, and 5mg quantity.

For Ipamorelin, researchers can record its independently supplied sequence, formula, molecular weight, identifier, and 5mg quantity.

Additional experiment-specific documentation may include:

  • Research concentration
  • Research model
  • Sample preparation
  • Controls
  • Analytical methods
  • Experimental conditions
  • Measured endpoints

This distinction is particularly useful when analyzing a multi-component formulation.

CJC 1295 and Alternative Search Formatting

Researchers and search users may encounter the product name written in several formats, including cjc 1295 and cjc1295.

The supplied product name specifically identifies the first component as CJC-1295 (No DAC).

These formatting variations can describe similar search intent, but molecular verification should rely on the supplied sequence and other technical specifications rather than punctuation or keyword formatting.

This page therefore avoids repeatedly using every variation throughout the copy.

Evaluating Scientific Literature

Scientific publications involving either component should be evaluated according to their specific experimental methodology.

Researchers should consider:

  • Exact material identity
  • Molecular characteristics
  • Experimental concentration
  • Research model
  • Study design
  • Appropriate controls
  • Exposure conditions
  • Analytical methodology
  • Experimental endpoints

A publication involving one material independently should not automatically be treated as evidence concerning the complete blend.

Differences in research models or experimental conditions can also limit direct comparison between studies.

Related OROS Research Materials

Researchers can explore OR-2T 5mg as a separately specified research product.

Another strength is available as OR-2T 10mg.

Researchers can also review OR-2T 20mg within the same catalog series.

Another independently specified OROS material is Pinealon 20mg.

Each product has separate specifications and should be evaluated independently rather than considered experimentally interchangeable.

Scientific Research Resources

Researchers can use PubChem to investigate available molecular records and chemical identifiers.

Peer-reviewed biomedical and experimental publications can be searched through PubMed.

The exact compound, molecular characteristics, research model, concentration, controls, methodology, and endpoints should be verified before comparing results between studies.

Research FAQ

What does this research blend contain?

The formulation contains 5mg of CJC-1295 (No DAC) and 5mg of Ipamorelin, providing 10mg total specified material.

How much of each component is supplied?

Each component contributes 5mg to the formulation.

What is the PubChem CID of the No DAC component?

The supplied PubChem CID is 56841945.

What is the PubChem CID for Ipamorelin?

The supplied identifier is 9831659.

What is the total quantity in the vial?

The two listed components provide 10mg total research material.

What size vial is supplied?

The product is supplied in a 3mL vial.

Does the vial capacity establish research concentration?

No. The 3mL vial capacity does not independently establish an experimental concentration or preparation volume.

Are CAS numbers supplied?

No CAS numbers were included in the supplied specifications, so none are being inferred.

Research Use Disclaimer

This CJC-1295 No DAC / Ipamorelin research blend is presented exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. Product quantities and vial capacity are research specifications and do not constitute human dosing or administration guidance. This information does not provide instructions for injection, self-administration, therapeutic use, diagnosis, treatment, bodybuilding, performance enhancement, or veterinary application.

Additional information
Net Weight

10mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 5mg, Ipamorelin 5mg (10mg Blend)”

Your email address will not be published. Required fields are marked *